Search

Your search keyword '"Atsunori Yorozu"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Atsunori Yorozu" Remove constraint Author: "Atsunori Yorozu"
144 results on '"Atsunori Yorozu"'

Search Results

1. Quality Indicators in Palliative Radiation Oncology: Development and Pilot Testing

2. Inconsistencies in assessment of pain endpoints in radiotherapy for painful tumors: Analysis of original articles in the Green and Red Journals

4. Evaluation of dose perturbations around iodine-125 seed sources in supplemental external beam prostate radiotherapy

5. Biochemical outcomes and toxicities in young men with prostate cancer after permanent iodine-125 seed implantation: Prospective cohort study in 6662 patients

6. Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer

8. Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose–response analyses for local control in the low-dose range

9. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial

10. Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation

11. Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy

12. Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer

13. Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy

15. Index and Nonindex Pain Endpoints in Radiation Therapy for Painful Tumors: A Secondary Analysis of a Prospective Observational Study

16. Inconsistencies in assessment of pain endpoints in radiotherapy for painful tumors: Analysis of original articles in the Green and Red Journals

17. Current status of prostate brachytherapy in Japan

18. Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907)

19. PD13-01 NOVEL SIMULATING MODEL OF THE SURVEILLANCE DURATION AFTER LOW DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER PATIENTS: AN INDIVIDUALIZED RISK-BASED METHOD APPLYING WEIBULL DISTRIBUTIONS

20. Quality Indicators in Palliative Radiation Oncology: Development and Pilot Testing

21. Intracardiac metastasis from unknown uterine cervical cancer with severe thrombocytopenia

22. Biochemical outcomes and predictive factors by risk group after permanent iodine-125 seed implantation: Prospective cohort study in 2,316 patients

23. Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of 125I brachytherapy and robot-assisted radical prostatectomy

24. Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study

25. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer

26. Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysis

27. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival

28. A case of extramammary Paget’s disease showed local recurrence and lymph nodes metastasis so early after radiation therapy

29. Machine Learning Algorithms for Late Toxicity Prediction after Prostate Permanent Brachytherapy

30. Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS)

31. Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)

32. Prospective study of direct radiation exposure measurements for family members living with patients with prostate 125 I seed implantation: Evidence of radiation safety

33. Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy

34. Long-term Outcomes of Very-high-risk versus High-risk Prostate Cancer Patients Treated with Brachytherapy-based Treatment

35. PO-0796: Observational study of radiotherapy plus cetuximab in patients with LA-SCCHN: JROSG12-2

36. Brachytherapy for Esophageal Cancer: Optimum Dose and Indications in the Modern Era

37. A Review of Permanent Prostate Brachytherapy as Practiced in Japan

38. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients

39. Does Androgen Deprivation Therapy Improve Ten-Year Clinical Outcomes of Intermediate Risk Prostate Cancer Patients Treated with Brachytherapy with or without External Beam Radiotherapy?

40. Long Term Outcomes of Prostate Brachytherapy and Its Predictors of Recurrence

41. PO-0836 Outcomes and factors by risk group after prostate brachytherapy: Cohort study in 2316 patients

42. PV-0628 Association of androgen deprivation duration and cardiovascular mortality in prostate cancer men

43. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study

44. Variability of treatment planning of seed implantation: A Japanese multicenter simulation study

45. Variations in Rectal Volumes and Dosimetry Values Including NTCP due to Interfractional Variability When Administering 2D-Based IG-IMRT for Prostate Cancer

46. Some Decline Of Urinary Toxicity In Patients Treated With I-125 Prostate Brachytherapy Boost During A 10-Year Period

47. Investigation of Risk Factors for PSA Relapse in NCCN Low-Risk Prostate Cancer Patients Receiving Iodine-125 Permanent Prostate Seed Implantation as Monotherapy

48. Patterns of Recurrence for Prostate Cancer Patients Treated with Brachytherapy-based Radiotherapy

49. A New Approach to the Risk Classification of Patients with Prostate Cancer Treated with I-125 Prostate Seed Implantation in a Japanese Nationwide Prospective Cohort Study

50. Novel Parameter Predicting Grade 2 Rectal Bleeding After Iodine-125 Prostate Brachytherapy Combined With External Beam Radiation Therapy

Catalog

Books, media, physical & digital resources